Gilead Sciences appoints Stacey Ma as EVP, Pharmaceutical Development and Manufacturing
Taiyin Yang, PhD, Executive Vice President, Pharmaceutical Development and Manufacturing to Retire After 29 Years at Gilead
Taiyin Yang, PhD, Executive Vice President, Pharmaceutical Development and Manufacturing to Retire After 29 Years at Gilead
Construction will begin in early 2023, and the plant is scheduled to go onstream in 2025
The site, located in Berkeley County, will be operated using the same quality standards as DuPont’s Healthcare Industries Materials Site, the company’s longstanding biopharmaceutical manufacturing site in Hemlock, Michigan
Auld is a seasoned Financial Executive with over 30 years of relevant experience
This agreement is in addition to the $92 million filling line expansion announced in November 2021
Lung cancer is the leading cause of cancer death in the USA, making up almost 25% of all cancer deaths
Lonza to expand inhalation services by adding capabilities at its Tampa (US) site as part of its continued focus on providing bioavailability enhancement series for global customers
The two companies will work together for the Prospective Evaluation of OrionAI – a revolutionary AI-based Diagnostic Assistant for Histological Examination of a variety of solid tumours beginning with Head and Neck Squamous Cell Carcinoma (HNSCC) Cancer
Investment with representation on the Board of Directors and technical know-how
Key senior hire will partner with Allison Ceraso, President and CCO, bolstering agency leadership amongst continued network momentum
Subscribe To Our Newsletter & Stay Updated